In summary, our findings indicate that a serum IL-8 concentration of 50 pg/mL or greater, measured at the initial clinical encounter, can effectively distinguish between fatal and non-fatal cases of kala-azar with high sensitivity and specificity, thereby aiding clinical decisions at the point of care. The gene discussed is CXCL8; the disease is visceral leishmaniasis.